Skip to main content
OpenTrials

Clinical trial condition

Meningioma

Explore clinical trials studying Meningioma. Study availability and eligibility vary by location and protocol.

186 public trials 62 recruiting studies
Refine in advanced search Browse all conditions

Meningioma trial results

Completed

Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma

NCT00045110

Conditions
Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, +28 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • National Cancer Institute Neuro-Oncology Branch Bethesda, Maryland, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

Imatinib Mesylate in Treating Patients With Recurrent Meningioma

NCT00045734

Conditions
Adult Grade I Meningioma, Adult Grade II Meningioma, Adult Grade III Meningioma, +16 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • National Cancer Institute Neuro-Oncology Branch Bethesda, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma

NCT00003590

Conditions
Adult Meningioma, Brain Diseases, Brain Neoplasms, +11 more
Locations
  • Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • CCOP - Western Regional, Arizona Phoenix, Arizona, United States
  • Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
View all 133 locations
View Trial Details
Completed

Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma

NCT00589784

Conditions
Brain Diseases, Brain Neoplasms, CNS Cancer, +42 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
  • Memorial Sloan-Kettering Cancer Center at Commack Commack, New York, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
View Trial Details

Related conditions